药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Etryptamine
Acteoside
The risk or severity of adverse effects can be increased when Acteoside is combined with Fluticasone.
Etryptamine
Deoxyspergualin
The risk or severity of adverse effects can be increased when Deoxyspergualin is combined with Fluticasone.
Etryptamine
Doxifluridine
The risk or severity of adverse effects can be increased when Doxifluridine is combined with Fluticasone.
Etryptamine
Trofosfamide
The risk or severity of adverse effects can be increased when Trofosfamide is combined with Fluticasone.
Etryptamine
Cepeginterferon alfa-2B
The risk or severity of adverse effects can be increased when Cepeginterferon alfa-2B is combined with Fluticasone.
Etryptamine
Gusperimus
The risk or severity of adverse effects can be increased when Gusperimus is combined with Fluticasone.
Etryptamine
Mizoribine
The risk or severity of adverse effects can be increased when Mizoribine is combined with Fluticasone.
Etryptamine
Guselkumab
The risk or severity of adverse effects can be increased when Guselkumab is combined with Fluticasone.
Etryptamine
Sirukumab
The risk or severity of adverse effects can be increased when Sirukumab is combined with Fluticasone.
Etryptamine
Brodalumab
The risk or severity of adverse effects can be increased when Brodalumab is combined with Fluticasone.
Etryptamine
Sarilumab
The risk or severity of adverse effects can be increased when Sarilumab is combined with Fluticasone.
Etryptamine
Peficitinib
The risk or severity of adverse effects can be increased when Peficitinib is combined with Fluticasone.
Etryptamine
Voclosporin
The risk or severity of adverse effects can be increased when Voclosporin is combined with Fluticasone.
Etryptamine
Pirarubicin
The risk or severity of adverse effects can be increased when Pirarubicin is combined with Fluticasone.
Etryptamine
Ravulizumab
The risk or severity of adverse effects can be increased when Ravulizumab is combined with Fluticasone.
Etryptamine
Ixekizumab
The risk or severity of adverse effects can be increased when Ixekizumab is combined with Fluticasone.
Etryptamine
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Antilymphocyte immunoglobulin (horse) is combined with Fluticasone.
Etryptamine
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Peginterferon beta-1a is combined with Fluticasone.
Etryptamine
Vilanterol
The risk or severity of adverse effects can be increased when Vilanterol is combined with Fluticasone.
Etryptamine
Dinutuximab
The risk or severity of adverse effects can be increased when Dinutuximab is combined with Fluticasone.